These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27669028)

  • 1. Polymyxin B Direct Hemoperfusion Using Regional Citrate-Calcium Anticoagulation: A Case Report.
    Sidoti A; Brogi E; Morse J; Collareta M; Vetrugno L; Giunta F; Forfori F
    A A Case Rep; 2016 Dec; 7(11):232-235. PubMed ID: 27669028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional citrate-calcium anticoagulation during polymyxin-B hemoperfusion: A case series.
    Forfori F; Brogi E; Sidoti A; Giraudini M; Monti G; Zarrillo N; Cantaluppi V; Ronco C
    Int J Artif Organs; 2018 Jun; 41(6):319-324. PubMed ID: 29577795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
    Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
    Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin dosing score protocol for anticoagulation during polymyxin B hemoperfusion.
    Lee CT; Chao A; Lai CH; Yeh YC
    J Formos Med Assoc; 2018 Jul; 117(7):652-653. PubMed ID: 29555453
    [No Abstract]   [Full Text] [Related]  

  • 5. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y; Obata T; Okamoto Y; Iwai K; Saito K; Yokoyama K; Takinami M; Tanifuji Y
    Ther Apher Dial; 2008 Oct; 12(5):374-80. PubMed ID: 18937720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
    Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
    Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM.
    Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H
    Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock.
    Sakamoto Y; Mashiko K; Obata T; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(5):646-50. PubMed ID: 17885340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C; Hara Y; Kuriyama N; Nakamura T; Nishida O
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients with Septic Shock.
    Inoue S; Sakamoto Y; Koami H; Yamada C K; Nagashima F; Miike T; Iwamura T; Obata T
    J Nippon Med Sch; 2018; 85(1):39-46. PubMed ID: 29540645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study.
    Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Summonti D; Celli P; Perrella S; Cappannoli A; Pietropaoli C; Tosi A; Diana B; Novelli G; Rossi M; Ginanni-Corradini S; Ferretti G; Berloco PB; Pietropaoli P
    Int J Artif Organs; 2007 Oct; 30(10):915-22. PubMed ID: 17992653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
    Ishizuka M; Terasaki A; Kubota K
    J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin B hemoperfusion: a mechanistic perspective.
    Ronco C; Klein DJ
    Crit Care; 2014 Jun; 18(3):309. PubMed ID: 25043934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock.
    Nakamura T; Kawagoe Y; Suzuki T; Shoji H; Ueda Y; Koide H
    Am J Med Sci; 2007 Oct; 334(4):244-7. PubMed ID: 18030179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion.
    Ishizuka M; Tago K; Kubota K
    Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Yamamoto Y
    ASAIO J; 2007; 53(3):324-8. PubMed ID: 17515723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of direct haemoperfusion through fibres immobilizing polymyxin B and nafamostat mesilate on endotoxaemia in conscious Guinea-pigs.
    Nakanowatari Y; Nemoto K; Hara S; Ninomiya N; Yamamoto Y
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):17-22. PubMed ID: 18047622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.